Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure (CHF)
1 other identifier
observational
100
1 country
1
Brief Summary
Shortness of breath, fatigue, and exercise intolerance are clinical symptoms of chronic heart failure (CHF). Recent studies suggested that peripheral impairment was the major cause of clinical symptoms, and mechanism may be related to neuroendocrine impairment and vascular smooth muscle dysfunction. It results in increased peripheral resistance that may influence limb blood flow, muscle fitness and activities of daily.The purposes of this study are
- 1.to compare muscular strength, endurance, and perfusion of quadriceps between CHF patients and healthy controls by isokinetic test and near-infrared spectroscopy (NIRS) and difference in activities of daily living
- 2.to compare endothelium function between CHF patients and healthy control subjects
- 3.the relationship between endothelium function, muscular strength, endurance, perfusion, and metabolism of quadriceps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 7, 2010
CompletedFirst Posted
Study publicly available on registry
June 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedJune 8, 2010
June 1, 2010
1 year
June 7, 2010
June 7, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
muscle strength and endurance
Measured by biodex
baseline
Secondary Outcomes (6)
skeletal muscle oxygenation response
baseline
Walking distance in 6-minute walking test
baseline
laser Doppler flowmetry combine iontophoresis
baseline
sit-to-stand test
baseline
questionnaire (functional activity and quality of life)
baseline
- +1 more secondary outcomes
Study Arms (3)
Cardiovascular disease
Diagnosis of cardiomyopathy or ischemic heart disease without heart failure
Chronic heart failure
Diagnosis of cardiomyopathy or ischemic heart disease LVEF \<40%
Control
Age and body built matched with chronic heart failure group
Eligibility Criteria
Chronic Heart Failure Coronary Disease Dilated Cardiomyopathy Control group without diagnosis of any heart disease
You may qualify if:
- Age 40-75 years
- Chronic heart failure: ejection fraction\<40% and at stable condition
- Coronary Disease and dilated cardiomyopathy without heart failure
- Control group without diagnosis of any heart disease
You may not qualify if:
- Clinical diagnosis of neuromusculoskeletal , pulmonary, or other systemic diseases that may affect the testing of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ying-Tai Wu, Ph.D
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 7, 2010
First Posted
June 8, 2010
Study Start
May 1, 2010
Primary Completion
May 1, 2011
Study Completion
May 1, 2011
Last Updated
June 8, 2010
Record last verified: 2010-06